IFNG and ocular melanoma: Donor #6 cGMP-hBM-MSC treated with either MM alone, MM plus IFN-γ, or MM plus the TGF-beta type I receptor inhibitor SB-431542, grew for three days with similar rates to near-confluence before osteogenic differentiation was initiated with OM-PL.